Drug Profile
Octenidine - CareFusion
Alternative Names: BDIP-0001Latest Information Update: 17 Sep 2021
Price :
$50
*
At a glance
- Originator CareFusion
- Class Antiseptics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 01 Dec 2020 Discontinued - Phase-II for Bacterial infections (Prevention) in USA (Topical) prior to December 2020
- 17 Mar 2017 CareFusion completes a phase II trial in Bacerial infections (Prevention) in USA (Topical) (NCT03140254)
- 01 Sep 2016 Phase-II clinical trials in Bacterial infections (Prevention) in USA (Topical) (NCT03140254)